MicroRNA‐139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL-Reference-Cited by-同舟云学术

MicroRNA‐139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL

Published:2019-07-03 Issue:12 Volume:79 Page:1435-1451
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Nam Robert K.¹,Benatar Tania²^ORCID,Wallis Christopher J. D.¹,Kobylecky Elizabeth²,Amemiya Yutaka³,Sherman Christopher⁴,Seth Arun²³⁴⁵

Affiliation:

1. Division of Urology, Sunnybrook Health Sciences Centre, Sunnybrook Research InstituteUniversity of Toronto Toronto Ontario Canada

2. Platform Biological Sciences, Sunnybrook Health Sciences Centre, Sunnybrook Research InstituteUniversity of Toronto Toronto Ontario Canada

3. Genomics Core FacilitySunnybrook Research Institute Toronto Ontario Canada

4. Department of Laboratory Medicine and PathobiologyUniversity of Toronto Toronto Ontario Canada

5. Faculty of DentistryUniversity of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23871

Reference88 articles.

1. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study

2. Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

3. Overdiagnosis and Overtreatment of Prostate Cancer

4. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer

5. MicroRNAs and their potential for translation in prostate cancer

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer and the cell cycle: Focusing on the role of microRNAs;Gene;2024-11

2. Crucial role of hsa-mir-503, hsa-mir-1247, and their validation in prostate cancer;Aging;2023-11-16

3. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer;Pathology - Research and Practice;2023-08

4. The role of miRNA in prostate cancer diagnosis, prognosis and treatment response: a narrative review;Future Oncology;2023-01

5. MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application?;Andrology;2022-08-21